Apprentice.io

Apprentice.io provides a cloud-based platform, Tempo Manufacturing Cloud, to help life science manufacturers accelerate the end-to-end drug product lifecycle. The platform connects distributed teams and sites, streamlining execution on the shop floor and optimizing operations through enterprise-wide visibility. From preclinical benchtop to large-scale commercial manufacturing, Tempo keeps global teams connected, empowered, and in sync.

Tempo Manufacturing Cloud comprises several products, including a Manufacturing Execution System (MES), a Laboratory Execution System (LES), Augmented Work Instructions (AWI), and Tandem Virtual Collaboration (TVC). The MES allows users to develop and release drug batches through coordination of materials, equipment, recipes, and personnel. The LES helps release drug batches faster with real-time quality control. AWI enables authoring and augmenting digital work instructions for execution on mobile and wearable devices. TVC is a virtual collaboration solution for replacing in-person site visits with real-time conferencing designed for pharma facilities.

In March 2023, Apprentice.io introduced the Connected Manufacturing Network (CMN), enabling manufacturers to streamline drug development by connecting all their manufacturing sites on a single platform. CMN facilitates centralized recipe management, optimization, and shared digital access to production runs and workflows for batch review and signoff.

Apprentice.io's platform leverages artificial intelligence, machine learning, and augmented reality to help organizations improve yield, quality, reduce deviations, and increase speed to market. The company played a crucial role in facilitating the manufacturing of approximately 370 million Covid-19 vaccine doses during the pandemic. As of 2023, Apprentice.io had raised USD 207 million in funding, experienced a 3.4x year-over-year growth rate, and achieved 218% net customer retention.